Xiretsa Overview

  • Year Founded
  • 2019

Year Founded

  • Status
  • Private

  • Employees
  • 4

Employees

  • Latest Deal Type
  • Accelerator/​Inc

  • Latest Deal Amount
  • $268K

  • Investors
  • 4

Xiretsa General Information

Description

Developer of antimicrobial molecular therapeutics designed for combating drug-resistant infections. The company's platform focuses on creating novel compounds with broad-spectrum activity against multiple bacterial and fungal pathogens, incorporates mechanisms to reduce susceptibility to existing resistance, emphasizes low cytotoxicity to human cells, and is engineered for potential systemic and topical applications, enabling healthcare and pharmaceutical sectors to address critical unmet needs in infection treatment and reduce the global impact of antibiotic-resistant diseases.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Accelerator/Incubator Backed
Corporate Office
  • DE
  • United States
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Corporate Office
  • DE
  • United States

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Xiretsa Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
5. Accelerator/Incubator 01-Mar-2023 $268K Completed Generating Revenue
4. Accelerator/Incubator 01-Jan-2021 Completed Generating Revenue
3. Accelerator/Incubator 17-Dec-2020 Completed Generating Revenue
2. Accelerator/Incubator Completed Generating Revenue
1. Angel (individual) Completed Generating Revenue
To view Xiretsa’s complete valuation and funding history, request access »

Xiretsa Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Xiretsa Investors (4)

Investor Name Investor Type Holding Investor Since Participating Rounds
INCATE Accelerator/Incubator
California Life Sciences Accelerator/Incubator
UC Startup Innovation Challenge Other
California NanoSystems Institute Accelerator/Incubator
To view Xiretsa’s complete investors history, request access »

Xiretsa FAQs

  • When was Xiretsa founded?

    Xiretsa was founded in 2019.

  • Where is Xiretsa headquartered?

    Xiretsa is headquartered in DE.

  • What is the size of Xiretsa?

    Xiretsa has 4 total employees.

  • What industry is Xiretsa in?

    Xiretsa’s primary industry is Drug Discovery.

  • Is Xiretsa a private or public company?

    Xiretsa is a Private company.

  • What is Xiretsa’s current revenue?

    The current revenue for Xiretsa is .

  • How much funding has Xiretsa raised over time?

    Xiretsa has raised $268K.

  • Who are Xiretsa’s investors?

    INCATE, California Life Sciences, UC Startup Innovation Challenge, and California NanoSystems Institute have invested in Xiretsa.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process